RMMI Corp. Announces Filing of the Final Prospectus and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
RMMI Corp. Announces Filing of the Final Prospectus and Initial Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.

CALGARY, Alberta, June 25, 2018 (GLOBE NEWSWIRE) -- RMMI Corp. (“ RMMI ”) announced today that it has obtained a receipt for its final long form prospectus (the “ Prospectus ”) filed with the securities regulatory authorities in the Provinces of Alberta, British Columbia and Ontario in connection with the proposed initial public offering (the “ IPO ”) of RMMI’s common shares at a price of $2.50 per common share. The IPO consists of a minimum offering of 1,700,000 common shares for aggregate gross proceeds of $4,250,000 and a maximum offering of 3,500,000 common shares for aggregate gross proceeds of $8,750,000. A copy of the Prospectus is available on SEDAR ( www.sedar.com ).

The IPO is being made on a commercially reasonable efforts basis and is being led by Canaccord Genuity Corp., as lead agent, and Haywood Securities Inc., as co-agent (collectively, the “ Agents ”). RMMI has granted to the Agents an over-allotment option (the “ Over-Allotment Option ”) that is exercisable at the Agents’ sole discretion, to offer for purchase and sale additional common shares in the capital of RMMI in an amount that is equal to 15% of the total number of common shares issued under the IPO at a price of $2.50 per common share. The Agents may exercise the Over-Allotment Option, in whole or in part, at any time on or before the date that is 60 days following the date of closing of the IPO.

The closing of the IPO is expected to occur on or about July 13, 2018, subject to customary closing conditions, at which time the common shares are expected to commence trading on the Canadian Securities Exchange (the “ CSE ”) under the symbol “RMMI”. The CSE has conditionally approved the listing of the common shares, subject to fulfilling customary CSE listing requirements.

No securities regulatory authority has either approved or disapproved of the contents of this news release. The common shares have not been and will not be registered under the United States Securities Act of 1933 , as amended (the “ U.S. Securities Act ”) or any state securities laws. Accordingly, the common shares may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of RMMI in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About RMMI Corp.

RMMI is an Alberta based company that will focus on the production, cultivation and sale of medical marijuana in various forms, including dried marijuana and cannabis oil. RMMI, through its wholly-owned subsidiary, Rocky Mountain Marijuana Inc., has applied for a Licence to Produce under the Access to Cannabis for Medical Purposes Regulations (Canada).  RMMI is currently at a development stage and has yet to obtain the requisite licence to commence operations.

For more information about RMMI, please visit https://www.rmmi.ca .

Forward Looking Statements

Certain statements contained in this news release constitute “forward-looking statements” or “forward-looking information” within the meaning of the applicable securities legislation (collectively, “ forward-looking statements ”). These statements relate to management’s expectations about future events, results of operations and RMMI’s future performance (both operational and financial) and business prospects. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “contemplate,” “continue,” “propose,” “predict,” “plan,” “goal,” “seek,” “believe,” “project,” “forecast,” “pursue,” “potential,” “objective,” “estimate,” “expect,” “strategy,” “future,” “likely,” “might,” “may,” “shall,” “should,” “could,” “will,” “capable,” and similar references to future periods. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Unless otherwise indicated, these statements speak only as of the date of this news release. In particular, this news release contains forward-looking statements pertaining to the following: the exercise of the Over-Allotment Option by the Agents (if any), the planned completion of the IPO and the terms thereof, the proceeds raised under the IPO and the listing of the common shares on the CSE.

Forward-looking statements are based on certain assumptions and analyses made by RMMI in light of the experience and perception of historical trends, current conditions and expected future developments and other factors it believes are appropriate and are subject to risks and uncertainties. In making the forward looking statements included in this news release, RMMI has made various material assumptions, including but not limited to, material assumptions related to the following: obtaining the necessary regulatory approvals from Health Canada and other governmental authorities; maintaining said regulatory approvals, if and when obtained; general business and economic conditions and RMMI’s ability to successfully execute its plans and intentions.

Although RMMI believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and RMMI cannot assure that actual results will be consistent with the forward-looking statements included in this news release. Given these risks, uncertainties and assumptions, prospective purchasers of common shares should not place undue reliance on the forward-looking statements in this news release. In fact, RMMI’s actual results could differ materially from those anticipated in the forward-looking statements as a result of the risk factors and other factors set forth in the Prospectus.

The forward-looking statements included in this news release are expressly qualified by this cautionary statement and, except as otherwise indicated, are made as of the date of this news release. RMMI does not undertake any obligation to publicly update or revise any forward-looking statements or departures from them except as required by applicable securities laws. All of the forward-looking statements contained in this news release are expressly qualified by the foregoing cautionary statements.

For more information, please contact:

RMMI Corp. #1050 – 639-5 th Avenue S.W. Calgary, AB T2P 0M9   

Earl Connors, President and Chief Executive Officer      403-984-6446     ec@rmmi.ca

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 24

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 6

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 7

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 15

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 7

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 11

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 2

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 7

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 15

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading

Top 5 Most Recently Viewed Articles

Seadrill and Petrobras Unite for Major $498 Million Deal

Updated Category News Views 246

Seadrill Secures Major Contract with Petrobras HAMILTON, Bermuda - Seadrill Limited (NYSE: SDRL), an offshore drilling contractor with a market capitalization of $2.46 billion and a trading price of $37.31, has successfully won a crucial contract with Brazilian oil giant Petrobras for its ultra-deepwater drillship, West Tellus. This significant agreement emerged from a...

Continue Reading
Investigation Launched into Acadia Healthcare Company’s Practices

Updated Category News Views 143

Acadia Healthcare Company Under Investigation Law Offices of Howard G. Smith has announced that it is conducting an investigation on behalf of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and its investors. This examination is prompted by potential violations of federal securities laws following serious allegations concerning the company’s operational practices....

Continue Reading
Cousins Maine Lobster Dishes New Lobster Roll Flight

Updated Category News Views 7

A Bite-Sized Maine Experience Get a whiff of this: Cousins Maine Lobster is rollin' out something that'll make your taste buds do a jig. They call it the Lobster Roll Flight, and it's about to shake things up for seafood lovers everywhere. Dropping on July 1st nationwide, this offering lets foodies sample three of Cousins' star rolls—Maine, Connecticut, and Garlic...

Continue Reading
Innovative Knee Support Product Designed for Pain Relief

Updated Category News Views 250

Introducing an Innovative Knee Support Solution In today's world, many individuals suffer from knee pain, often due to issues such as arthritis or weakened quadricep muscles. Recognizing this challenge, a doctor of physical therapy and an inventive team have come together to create a groundbreaking solution called the KNEE SUPPORT. This innovative product stands out as a...

Continue Reading
Recent Forecast Changes for TELA Bio Following Third Quarter Results

Updated Category News Views 185

Recent Forecast Changes for TELA Bio TELA Bio Inc (NASDAQ: TELA) has recently reported its third-quarter earnings, which presented a mix of results. The company incurred a loss of 19 cents per share, slightly better than analysts had anticipated at 20 cents. However, TELA Bio's quarterly sales totaled $20.7 million, falling short of estimates that predicted $21.8 million....

Continue Reading